The Regulatory Updates section monitors pharma and approval across India's pharmaceutical sector. Significant developments around drug continue to draw attention from regulators, investors, and industry professionals, reflecting the dynamic pace of change in this space.
Recent coverage has drawn from EquityBulls, 데일리팜, and Drug Topics, among other publications. This section is updated as new stories emerge, ensuring readers have access to the most current information shaping this part of the pharmaceutical landscape.
For authoritative reference, CDSCO Drug Approvals and US FDA Drug Approvals publish official guidance and regulatory documentation relevant to these topics. Peer-reviewed research and clinical data can be accessed through WHO Prequalification Programme.
Showing 30 articles
-
Aurobindo Pharma receives final US FDA approval for Tofacitinib Tablets, 5 mg and 10 mg
Aurobindo Pharma receives final US FDA approval for Tofacitinib Tablets, 5 mg and 10 mg EquityBulls
-
데일리팜코리아, 데일리팜 영문뉴스, dailypharmkorea
데일리팜코리아, 데일리팜 영문뉴스, dailypharmkorea 데일리팜
-
Alabama Board of Medical Examiners Issues Warning of Non-FDA-Approved Peptides
Alabama Board of Medical Examiners Issues Warning of Non-FDA-Approved Peptides Drug Topics
-
Medicus Pharma advances SkinJect toward registrational trial for rare Gorlin Syndrome
Medicus Pharma advances SkinJect toward registrational trial for rare Gorlin Syndrome Proactive financial news
-
Newspoint: Khorakiwala’s antibiotic bet
Newspoint: Khorakiwala’s antibiotic bet financialexpress.com
-
Breaking !! CMS Hemp Program Appeal Filed in Federal Appellate Court
Breaking !! CMS Hemp Program Appeal Filed in Federal Appellate Court newswire.com
-
4 Biotech Stocks Investors Should Watch in 2026
4 Biotech Stocks Investors Should Watch in 2026 TradingView
-
Q&A: Why Pharma Supply Chains Are Turning to AI
Q&A: Why Pharma Supply Chains Are Turning to AI Pharmaceutical Commerce
-
Alembic Pharma Bags USFDA Approval for Generic Haldol Tablets, Targets USD 27 Million Market
Alembic Pharma Bags USFDA Approval for Generic Haldol Tablets, Targets USD 27 Million Market Medical Dialogues
-
Mezzion Pharma Completes FUEL-2 Phase 3 Regulatory Milestone
Mezzion Pharma Completes FUEL-2 Phase 3 Regulatory Milestone PR Newswire
-
데일리팜코리아, 데일리팜 영문뉴스, dailypharmkorea
데일리팜코리아, 데일리팜 영문뉴스, dailypharmkorea 데일리팜
-
Shionogi’s New U.S. And China Drug Approvals Shift Growth Outlook
Shionogi’s New U.S. And China Drug Approvals Shift Growth Outlook simplywall.st
-
Why decades-old medicines can still create new insurance risks
Why decades-old medicines can still create new insurance risks Insurance Business
-
FDA approves third interchangeable insulin glargine biosimilar Langlara
FDA approves third interchangeable insulin glargine biosimilar Langlara Generics and Biosimilars Initiative
-
Aurobindo Pharma Gets USFDA Nod For Arthritis Drug With $494 Million Market Potential
Aurobindo Pharma Gets USFDA Nod For Arthritis Drug With $494 Million Market Potential Trade Brains
-
Secretary for Health concludes visit to Fujian (with photos)
Secretary for Health concludes visit to Fujian (with photos) info.gov.hk
-
Alembic Pharmaceuticals in Focus After Receiving USFDA Approval For Drug With $27 Million Market Opportunity
Alembic Pharmaceuticals in Focus After Receiving USFDA Approval For Drug With $27 Million Market Opportunity Trade Brains
-
DH invites representatives from GBA Center for Drug Evaluation and Inspection of National Medical Products Administration to brief local pharmaceutical industry on latest developments in drug regulation and registration evaluation in Chinese Mainland (with
DH invites representatives from GBA Center for Drug Evaluation and Inspection of National Medical Products Administration to brief local pharmaceutical industry on latest developments in drug regulation and registration evaluation in Chinese Mainland (with info.gov.hk
-
United States Pharmaceutical Market Set to Reach US$ 979.25 Billion by 2033 as Innovation, Aging Population, and Specialty Drugs Drive Growth
United States Pharmaceutical Market Set to Reach US$ 979.25 Billion by 2033 as Innovation, Aging Population, and Specialty Drugs Drive Growth vocal.media
-
Flerie’s portfolio company Xspray Pharma receives CRL from FDA for Nilopki™
Flerie’s portfolio company Xspray Pharma receives CRL from FDA for Nilopki™ TradingView
-
Aurobindo Pharma Secures USFDA Approval for Tofacitinib Tablets
Aurobindo Pharma Secures USFDA Approval for Tofacitinib Tablets Siliconindia
-
Alembic Pharma Gets USFDA Nod For Haloperidol Tablets
Alembic Pharma Gets USFDA Nod For Haloperidol Tablets HDFC Sky
-
Madras High Court Holds Chennai API Maker's Export Of Diabetes Drug Vildagliptin To Egypt Infringed...
Madras High Court Holds Chennai API Maker's Export Of Diabetes Drug Vildagliptin To Egypt Infringed... LiveLawBiz
-
Hyderabad-based Aurobindo Pharma gets US FDA nod for arthritis and colitis drug, eyes $494 million market
Hyderabad-based Aurobindo Pharma gets US FDA nod for arthritis and colitis drug, eyes $494 million market financialexpress.com
-
Lupin Receives Approval from U.S. FDA for Ranluspec™(ranibizumab) Injection
Lupin Receives Approval from U.S. FDA for Ranluspec™(ranibizumab) Injection BioSpace
-
Kenya Poised as Regional Pharmaceutical Hub but Barriers Remain
Kenya Poised as Regional Pharmaceutical Hub but Barriers Remain Science Africa
-
Aurobindo Pharma officials to attend UBS virtual investor meet
Aurobindo Pharma officials to attend UBS virtual investor meet scanx.trade
-
Shelter Pharma schedules H2 and FY26 investor call for June 10
Shelter Pharma schedules H2 and FY26 investor call for June 10 scanx.trade
-
Alembic Pharma receives USFDA approval for Haloperidol tablets
Alembic Pharma receives USFDA approval for Haloperidol tablets Business Standard
-
Otsuka's Voyxact Shows Kidney Function Preservation in Late-Stage IgAN Trial, Setting Stage for Full FDA Approval
Otsuka's Voyxact Shows Kidney Function Preservation in Late-Stage IgAN Trial, Setting Stage for Full FDA Approval IndiaMedToday